Nephrosis 2 Idiopathic Steroid-Resistant Protein |
|||
| 20-abx262803 | Abbexa |
|
|
Nephrosis 2 Idiopathic Steroid-Resistant Protein |
|||
| abx262803-10mg | Abbexa | 10 mg | EUR 325 |
Nephrosis 2 Idiopathic Steroid-Resistant Protein |
|||
| abx262803-25mg | Abbexa | 25 mg | EUR 6575 |
Nephrosis 2 Idiopathic Steroid-Resistant Protein |
|||
| abx262803-5mg | Abbexa | 5 mg | EUR 225 |
Diseased Human Lung Fibroblasts, Idiopathic Pulmonary Fibrosis |
|||
| ABC-TC5520 | AcceGen | 1 vial | Ask for price |
|
Description: IPF (Idiopathic Pulmonary Fibrosis) is a fatal disease that usually affects adults between the ages of 50-70. The disease is characterized by progressive decline in lung function resulting from scarring of lung tissue.IPF varies from person to person where in some, fibrosis happens quickly, while the process can be much slower in others. IPF has no cure yet and both geneticand environmental factors are attributed to the development of the disease. Genetics may play a role in causing IPF, and cigarette smoking is the most accepted risk factor in increasing the chances of developing IPF. Recent research has helped doctors understand the disease more closely so they can more quickly diagnose it than in the past. Efforts are still underway in the research community to understand the pathways of disease progression and subsequently develop cures for IPF. IPF was once thought to be a chronic inflammatory process but recent evidence suggests that the abnormal activation of alveolar epithelial cells (AECs) induce over-activation of fibrotic response. The fibroblast and myofibroblast foci secrete excessive amounts of collagens, leading to scarringand destruction of the lung architecture. The mechanisms that link IPF with ageing and aberrant epithelial activation are unknown. |
|||
Idiopathic Autism Spectrum Disorder Fibroblastic Cell Line (sc119) |
|||
| T6358 | ABM | 5x10^5 cells / 1.0 ml | EUR 350 |
Idiopathic Autism Spectrum Disorder Fibroblastic Cell Line (sc166) |
|||
| T6359 | ABM | 5x10^5 cells / 1.0 ml | EUR 350 |
Idiopathic Autism Spectrum Disorder Fibroblastic Cell Line (sc174) |
|||
| T6360 | ABM | 5x10^5 cells / 1.0 ml | EUR 350 |
Idiopathic Autism Spectrum Disorder Fibroblastic Cell Line (sc204) |
|||
| T6361 | ABM | 5x10^5 cells / 1.0 ml | EUR 350 |
Idiopathic Autism Spectrum Disorder Fibroblastic Cell Line (sc222) |
|||
| T6362 | ABM | 5x10^5 cells / 1.0 ml | EUR 350 |
Idiopathic Autism Spectrum Disorder Fibroblastic Cell Line (sc229) |
|||
| T6363 | ABM | 5x10^5 cells / 1.0 ml | EUR 350 |
Nephrosis 2 Idiopathic Steroid-Resistant Human Recombinant |
|||
| rAP-4197 | Angio Proteomie | Inquiry | Ask for price |
Human Idiopathic Pulmonary Fibrosis (IPF) Peripheral Blood Mononuclear Cells |
|||
| ABC-TC4364 | AcceGen | 1 vial | Ask for price |
|
Description: Idiopathic pulmonary fibrosis is a chronic, progressive lung disease that results in scarring (fibrosis) of the lungs. Clinical data may include: Medication (current and historical), Disease severity, Lung function test results (FEV1, FEVC, PEF）. |
|||
NPHS2 (untagged)-Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2) |
|||
| SC304144 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Primary Idiopathic Pulmonary Fibrosis Lung Parenchymal Fibroblasts |
|||
| T5419 | ABM | 1 x 10^6 / 1.0 ml | Ask for price |
NPHS2 Nephrosis 2 Idiopathic Steroid-Resistant Human Recombinant Protein |
|||
| PROTQ9NP85 | BosterBio | Regular: 10ug | EUR 380.4 |
|
Description: NPHS2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (Val125-Leu383) containing 269 amino acids including a 10 aa His tag at N-terminus. The total calculated molecular mass is 30.2kDa. |
|||
NPHS2 (GFP-tagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2) |
|||
| RG212676 | Origene Technologies GmbH | 10 µg | Ask for price |
NPHS2 (Myc-DDK-tagged)-Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2) |
|||
| RC212676 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), mGFP tagged |
|||
| RC212676L2 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), mGFP tagged |
|||
| RC212676L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Rabbit Anti Human ESR2 Monoclonal Clone IDI-5 |
|||
| IRBAHUESR2IDI5C100UL | Innovative research | each | EUR 496 |
|
Description: Rabbit Anti Human ESR2 Monoclonal Clone IDI-5 |
|||
3`UTR clone of nephrosis 2 idiopathic steroid-resistant (podocin) (NPHS2) for miRNA target validation |
|||
| SC208552 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Primary Idiopathic Pulmonary Arterial Hypertension (IPAH) Bronchial Epithelial Cells |
|||
| T5472 | ABM | 5 x 10^5 / 1.0 ml | Ask for price |
Lenti ORF clone of Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), Myc-DDK-tagged |
|||
| RC212676L1 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), Myc-DDK-tagged |
|||
| RC212676L3 | Origene Technologies GmbH | 10 µg | Ask for price |
NPHS2 (untagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), transcript variant 2 |
|||
| SC335292 | Origene Technologies GmbH | 10 µg | Ask for price |
NPHS2 (myc-DDK-tagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), transcript variant 2 |
|||
| RC237398 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, NPHS2 (Myc-DDK tagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), 200ul, >10^7 TU/mL |
|||
| RC212676L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NPHS2 (mGFP-tagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), 200ul, >10^7 TU/mL |
|||
| RC212676L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NPHS2 (Myc-DDK tagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), 200ul, >10^7 TU/mL |
|||
| RC212676L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NPHS2 (mGFP-tagged) - Human nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2), 200ul, >10^7 TU/mL |
|||
| RC212676L4V | Origene Technologies GmbH | 200 µl | Ask for price |
IDI2 antibody |
|||
| 31932 | SAB | 100ul | EUR 319 |
IDI2 antibody |
|||
| 31932-100ul | SAB | 100ul | EUR 302.4 |
IDI2 antibody |
|||
| 31932-50ul | SAB | 50ul | EUR 224.4 |
IDI1 antibody |
|||
| 22782 | SAB | 100ul | EUR 479 |
IDI1 antibody |
|||
| 22782-100ul | SAB | 100ul | EUR 468 |
IDI2 Antibody |
|||
| 39580-100ul | SAB | 100ul | EUR 468 |
IDI2 Antibody |
|||
| E95085 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
IDI1 Antibody |
|||
| DF13081 | Affbiotech | 200ul | EUR 420 |
IDI1 Antibody |
|||
| DF13081-100ul | Affinity Biosciences | 100ul | EUR 280 |
IDI1 Antibody |
|||
| DF13081-200ul | Affinity Biosciences | 200ul | EUR 350 |
IDI2 Antibody |
|||
| E305399 | EnoGene | 100ug/200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
IDI1 Antibody |
|||
| 1-CSB-PA010994GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against IDI1. Recognizes IDI1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
IDI2 Antibody |
|||
| 1-CSB-PA010995GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against IDI2. Recognizes IDI2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
IDI1 antibody |
|||
| 70R-17881 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal IDI1 antibody |
|||
IDI2 antibody |
|||
| 70R-17882 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal IDI2 antibody |
|||
IDI1 antibody |
|||
| 70R-3705 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal IDI1 antibody raised against the middle region of IDI1 |
|||
IDI1 antibody |
|||
| 70R-12958 | Fitzgerald | 100 ul | EUR 550 |
|
Description: Affinity purified Rabbit polyclonal IDI1 antibody |
|||
IDI2 Antibody |
|||
| 1-CSB-PA871603LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against IDI2. Recognizes IDI2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
IDI1 Antibody |
|||
| GWB-MT518E | GenWay Biotech | 50ug | Ask for price |